Cargando…

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

OBJECTIVE: To investigate the association of concurrent use of oral anticoagulants (OACs) and sulfonylureas and the risk of hypoglycemia in individuals with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: A retrospective cohort study was conducted between 2001 and 2017 using electronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alwafi, Hassan, Wong, Ian C. K., Naser, Abdallah Y., Banerjee, Amitava, Mongkhon, Pajaree, Whittlesea, Cate, Alsharif, Alaa, Wei, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445245/ https://www.ncbi.nlm.nih.gov/pubmed/36082271 http://dx.doi.org/10.3389/fmed.2022.893080

Ejemplares similares

Epidemiology and treatment of atrial fibrillation in patients with type 2 diabetes in the UK, 2001–2016
por: Alwafi, Hassan, et al.
Publicado: (2020)

Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK
por: Alwafi, Hassan, et al.
Publicado: (2020)

Statin‐related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all‐cause mortality
por: Insani, Widya N., et al.
Publicado: (2022)

Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021)

Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis
por: Braet, Corey, et al.
Publicado: (2020)

Alcohol brief intervention delivered in UK community pharmacies: customers’ experiences
por: Whittlesea, Cate, et al.
Publicado: (2012)

SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020)

Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care
por: Mitchell, Sabrina L, et al.
Publicado: (2020)

A Case of Hypoglycemia With Concomitant Use of a Sulfonylurea and Clopidogrel
por: Ruiz, Brent, et al.
Publicado: (2022)

The effectiveness of octreotide at different doses for sulfonylurea-induced hypoglycemia following overdose
por: Gul, M, et al.
Publicado: (2007)

Stress Cardiomyopathy Induced by Refractory Hypoglycemia Due to Acute Sulfonylurea Intoxication
por: Shah, Binoy K, et al.
Publicado: (2023)

Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study
por: Naser, Abdallah Y., et al.
Publicado: (2019)

Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis
por: Insani, Widya N., et al.
Publicado: (2021)

Community pharmacy-based alcohol brief intervention in the UK: significant alcohol consumption reduction in risky drinkers
por: Khan, Natasha, et al.
Publicado: (2012)

Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2021)

Discordant Timing of Hypoglycemic Agent Screening Causing Delayed Diagnosis of Sulfonylurea-Induced Hypoglycemia
por: Folick, Andrew, et al.
Publicado: (2022)

SAT156 Two Cases Of Hypoglycemia From Inhalation Of Heroin Adulterated With A Sulfonylurea
por: Kim, Keun Young, et al.
Publicado: (2023)

Patient and public perception and experience of community pharmacy services post-discharge in the UK: a rapid review and qualitative study
por: Khayyat, Sarah, et al.
Publicado: (2021)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

The safety and efficacy of the use of oral anticoagulant medications in patients with diabetes mellitus: A systematic review
por: Alwafi, Hassan, et al.
Publicado: (2021)

The association between dementia and the risk of hypoglycaemia events among patients with diabetes mellitus: a propensity-score matched cohort analysis
por: Alsharif, Alaa A., et al.
Publicado: (2023)

Cost of hospitalisation and length of stay due to hypoglycaemia in patients with diabetes mellitus: a cross-sectional study
por: Naser, Abdallah Y., et al.
Publicado: (2020)

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008)

Hospital admissions due to infectious and parasitic diseases in England and Wales between 1999 and 2019: an ecological study
por: Sweiss, Kanar, et al.
Publicado: (2022)

Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
por: Zawawi, Ayat, et al.
Publicado: (2021)

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan
por: Naser, Abdallah Y, et al.
Publicado: (2018)

Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72-Hour Fast
por: Abraham, Alice, et al.
Publicado: (2015)

Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study
por: Wong, Carlos K. H., et al.
Publicado: (2019)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Effectiveness of alcohol brief intervention delivered by community pharmacists: study protocol of a two-arm randomised controlled trial
por: Dhital, Ranjita, et al.
Publicado: (2013)

Impact of ACEIs and ARBs-related adverse drug reaction on patients’ clinical outcomes: a cohort study in UK primary care
por: Insani, Widya N, et al.
Publicado: (2023)

Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross‐sectional study
por: Matsuoka, Atsuko, et al.
Publicado: (2019)

Adding Sodium–Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jiang, Meng, et al.
Publicado: (2021)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset
por: Worth, Chris, et al.
Publicado: (2022)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

The effects of fibrinolytic before referring STEMI patients: A systematic review and meta-analysis
por: Mongkhon, Pajaree, et al.
Publicado: (2017)

Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0i0fj2u6huhq6mh04jpakooi88